← Eichor
Study identifier: NCT02595255 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)

Condition: Fertility Preservation · Lymphoma · Pediatrics Cancer  ·  Sponsor: Erasme University Hospital

PhaseN/A
Planned participants275
Who can joinFemale, 3 Years to 14 Years
Healthy volunteersNo

About this study

While most of the children spontaneously recover menstruation or experienced normal puberty after chemotherapy, their ovarian reserve may be impaired by treatment inducing future infertility. Fertility preservation is currently proposed for selected prepubertal patients with a high risk of premature ovarian failure after treatment (mostly conditioning regimen for bone marrow transplantation). For patients with low or moderate risks, counselling is very difficult and no fertility preservation procedure is usually proposed for these patients as no marker of the ovarian reserve has been validated in this young population to assess the individual risk. The primary objective of the study is to prevent long-term treatment-related infertility by detecting the young patients who normally progressed to menarche but have a reduced ovarian reserve. These patients may benefit from particular follow-up and fertility preservation procedure.

This description comes directly from the study's public registry record.

Talk to the study team

Isabelle Demeestere, PhD  ·  +32 2 555 65 92  ·  idemeest@ulb.ac.be

Julie Dechene  ·  +32 2 555 63 58  ·  jdechene@ulb.ac.be

Always discuss trial participation with your own doctor first.

Locations (10)

Centre Hospitalier Chrétien (CHC)- Clinique de l'espéranceMontegnée, Liège, BelgiumRecruiting
Universitair Ziekenhuis AntwerpenAntwerp, BelgiumRecruiting
Hôpital Universitaire Reine Fabiola (HUDERF)Brussels, BelgiumRecruiting
Universitair Ziekenhuis BrusselsBrussels, BelgiumRecruiting
UZ-GentGhent, BelgiumNot Yet Recruiting
Universitair Ziekenhuis LeuvenLeuven, BelgiumRecruiting
Centre Hospitalier Régional (CHR)-CitadelleLiège, BelgiumRecruiting
Centre Oscar LambretLille, FranceRecruiting
CHRU Lille-Hôpital Jeanne de FlandreLille, FranceRecruiting
Hôpital Robert DebréParis, FranceNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02595255